Skip to main content

Shah Prem S's Form 4 filing

CVS Health Corp (CVS) · filed Mar 18, 2022

Accession no.
0001127602-22-009964
Filed
Mar 18, 2022
Trade date
Mar 17, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $493.1K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shah Prem SCIK 0001900910Officer (EVP and Co-President of Retail)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 17, 2022Common StockSSaleDisposed−1,689$106.65−$180,131.8559,071.24Direct
Mar 17, 2022Common StockMOption exerciseAcquired+2,935$104.82+$307,646.762,006.24Direct
Mar 17, 2022Common StockSSaleDisposed−2,935$106.65−$313,017.7559,071.24Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 17, 2022Common StockMOption exerciseDisposed−2,935$0.00$02,935Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)